1. Home
  2. KEYS vs BDX Comparison

KEYS vs BDX Comparison

Compare KEYS & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keysight Technologies Inc.

KEYS

Keysight Technologies Inc.

N/A

Current Price

$307.26

Market Cap

60.9B

Sector

Industrials

ML Signal

N/A

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

N/A

Current Price

$197.96

Market Cap

54.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEYS
BDX
Founded
1939
1897
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.9B
54.6B
IPO Year
2014
1998

Fundamental Metrics

Financial Performance
Metric
KEYS
BDX
Price
$307.26
$197.96
Analyst Decision
Buy
Buy
Analyst Count
12
16
Target Price
★ $418.00
$195.57
AVG Volume (30 Days)
962.3K
★ 1.4M
Earning Date
11-19-2026
11-05-2026
Dividend Yield
N/A
★ 2.12%
EPS Growth
★ 39.89
N/A
EPS
★ 5.93
1.59
Revenue
$5,375,000,000.00
★ $21,840,000,000.00
Revenue This Year
$32.38
N/A
Revenue Next Year
$15.39
$2.27
P/E Ratio
★ $55.67
$124.49
Revenue Growth
7.95
★ 8.24
52 Week Low
$167.23
$140.11
52 Week High
$389.93
$213.08

Technical Indicators

Market Signals
Indicator
KEYS
BDX
Relative Strength Index (RSI) 33.81 62.99
Support Level $270.75 $195.63
Resistance Level $309.50 $200.47
Average True Range (ATR) 12.32 3.73
MACD -4.29 0.38
Stochastic Oscillator 3.96 79.54

Price Performance

Historical Comparison
KEYS
BDX

About KEYS Keysight Technologies Inc.

Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.

About BDX Becton Dickinson and Company

Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Share on Social Networks: